ArticleAnnals of intensive care2026
Early sitting within 72 hours in the intensive care unit and post-intensive care outcomes: a multicenter cohort study.
Article in Annals of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Early mobilization is recommended in the intensive care unit (ICU), yet clinically meaningful early milestones remain unclear. We investigated whether achievement of sitting within 72 h of ICU admission was associated with post-intensive care outcomes among ICU survivors who underwent rehabilitation. Methods: In this multicenter observational cohort study, we included mechanically ventilated adult ICU survivors who underwent rehabilitation. Early sitting was defined as achievement of sitting at the bedside within 72 h after ICU admission. The primary outcome was death or functional decline at 3 months after hospital discharge, assessed using the Kihon Checklist. Prespecified secondary and exploratory outcomes included domain-specific impairments (physical, cognitive, and depressive), hospital readmission, and a composite of readmission or death within 3 months. Overlap propensity score weighting was used to balance baseline covariates. Multiple prespecified sensitivity analyses (48-h alternative definition, landmark analysis, exclusion of never-sitters, adjustment for Day-3 clinical status and rehabilitation dose) and Benjamini-Hochberg (BH) multiplicity adjustment were performed. Results: Among 423 patients, 173 achieved early sitting (≤72 h) and 250 did not. After overlap weighting, baseline characteristics were balanced. Early sitting was not associated with the primary outcome (adjusted risk ratio [aRR] 0.94, 95% confidence interval [CI] 0.80-1.09; p = 0.401). In exploratory analyses, early sitting was associated with a lower risk of cognitive domain impairment or death (aRR 0.80, 95% CI 0.67-0.97; p = 0.024; BH-adjusted p = 0.096) and of readmission or death (aRR 0.53, 95% CI 0.32-0.88; p = 0.014; BH-adjusted p = 0.027). No individual KCL item showed a clear association after weighting, and the cognitive association was not observed under a stricter definition. Associations with readmission-related outcomes were attenuated after adjustment for Day-3 clinical status. Conclusion: Achieving sitting within 72 h of ICU admission was not associated with death or functional decline at 3 months. The exploratory associations with cognitive-functional impairment and readmission-related outcomes may reflect the selection of clinically stable patients for early sitting rather than an effect of sitting itself. These findings support the feasibility of early sitting in clinically stable patients but do not establish early sitting as a therapeutic target; randomized trials are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.